Upadacitinib has a number of adverse effects.

- Upper respiratory tract infections (URTI) (14%)

- Nausea (4%)

- Elevated liver enzymes (2%)

- Fever (1%)

- Cough (2%)

Upper respiratory tract infections (URTI) include:

- Acute sinusitis

- Laryngitis

- Nasopharyngitis

- Oropharyngeal pain

- Pharyngitis

- Pharyngotonsillitis

- Rhinitis

- Sinusitis

- Tonsillitis

- Viral upper respiratory tract infection

The adverse effects were observed in placebo-controlled studies in subjects administered 15mg orally of upadacitinib.